|1 to 10 of 41||Next||Last|
This new technique could enable researchers to study how neurological conditions develop, as well as to test new therapies. The new technology also could help to advance research into gene therapies that are derived from a patient’s own cells.
President Trump has signed into law the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act -- legislation that, for the first time, will create a public health infrastructure across the country to combat Alzheimer’s disease and preserve brain health.
Although the holidays can be especially stressful for families living with Alzheimer’s, maintaining or adapting family rituals and traditions can help all family members feel connected. Follow these tips to help you have an enjoyable holiday season...
Researchers at Johns Hopkins Medicine have identified in live human brains new radioactive “tracer” molecules that bind to and “light up” tau tangles, a protein associated with a number of neurodegenerative diseases including Alzheimer’s disease and other related dementias.
Old age is the greatest risk factor for many diseases, including Alzheimer’s disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.
High blood sugar medication may ease the symptoms of Alzheimer's, according to a new study. Earlier research found the brains of people with both Alzheimer's and diabetes had fewer lesions compared with non-diabetics, and the new study indicates a likelihood that the diabetes drugs those subjects took, such as metformin, protected them from the lesions.
Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer’s disease in a matter of seconds. The researchers show that the small blood vessels in the retina at the back of the eye are altered in patients with Alzheimer’s.
In case you missed it, the National Institute on Aging (NIA) and the Alzheimer’s Association, in advance of the Association’s International Conference last month, hosted a pre-conference symposium titled, “Enabling Precision Medicine for Alzheimer’s Disease Through Open Science.”
Work by researchers at the Univerity of Virginia may provide doctors an entirely new path to treat or prevent Alzheimer’s disease, age-related memory loss, and other neurodegenerative diseases.
The first dementia prevalence data from a large population of lesbian, gay and bisexual older adults was reported this past week at the 2018 Alzheimer’s Association International Conference in Chicago.
|1 to 10 of 41||Next||Last|